Could hepatitis c-infected hearts save lives? new trial aims to find out

NCT ID NCT03383419

Recruiting now Disease control Sponsor: Baylor Research Institute Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether hearts from donors with hepatitis C can be safely transplanted into people without the virus. Participants will receive antiviral medication after transplant to clear the infection. The goal is to expand the donor pool and reduce wait times for heart transplant.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEART FAILURE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

heart failure

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HEART FAILURE

Contacts and locations

Locations

Baylor University Medical Center
RECRUITING

Dallas, Texas, 75246, United States
Cedars-Sinai Medical Center
RECRUITING

Los Angeles, California, 90048, United States
Duke University Medical Center
ACTIVE_NOT_RECRUITING

Durham, North Carolina, 27705, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.